Hyperbaric Oxygen Therapy Shows Promise for Reversing Age-Related Blood Vessel Decline

This completed clinical trial investigated hyperbaric oxygen therapy as a potential anti-aging intervention, focusing on its ability to stimulate new blood vessel formation in elderly participants. The research was based on emerging evidence that HBOT could improve tissue blood flow and oxygenation while promoting cellular repair mechanisms.

The study enrolled 62 elderly participants at Assaf-Harofeh Medical Center between December 2016 and January 2020. Participants underwent hyperbaric oxygen therapy, which involves breathing pure oxygen in a pressurized chamber that increases oxygen concentration in blood and tissues beyond normal levels.

Researchers hypothesized that HBOT would address aging-related organ dysfunction through three key mechanisms: restoring mitochondrial function in cells, mobilizing stem cells for tissue repair, and inducing angiogenesis - the formation of new blood vessels. The trial measured changes in blood vessel formation and tissue oxygenation to assess these effects.

While specific results from this completed trial require further publication, the research addresses a critical aspect of aging - declining blood vessel function and reduced tissue oxygenation. As we age, our cardiovascular system becomes less efficient at delivering oxygen and nutrients to organs, contributing to functional decline.

This trial represents growing interest in hyperbaric oxygen therapy as a longevity intervention. If successful, HBOT could offer a non-pharmaceutical approach to maintaining vascular health and organ function during aging, potentially extending healthspan through improved cellular energy production and tissue repair mechanisms.